Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew N Phillips

Showing results (171-180 of 287) with videos related to

Pageof 29
Sort By:
BMC Medicine|April 3, 2016
Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaborationCaroline A Sabin, Peter Reiss, Lene Ryom, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 29, 2013
Association between ALT level and the rate of cardio/cerebrovascular events in HIV-positive individuals: the D: A: D studyCaroline A Sabin, Lene Ryom, Helen Kovari, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2010
Changes in lipids and lipoprotein particle concentrations after interruption of antiretroviral therapyFiona C Lampe, Daniel A Duprez, Lewis H Kuller, et al.
Journal of the International AIDS Society|July 23, 2019
Strengthening the scale-up and uptake of effective interventions for sex workers for population impact in ZimbabweFrances M Cowan, Sungai T Chabata, Sithembile Musemburi, et al.
Journal of the International AIDS Society|June 29, 2019
Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START studyJose R Castillo-Mancilla, Andrew N Phillips, James D Neaton, et al.
The International Journal on Drug Policy|January 25, 2021
Recreational drug use and use of drugs associated with chemsex among HIV-negative and HIV-positive heterosexual men and women attending sexual health and HIV clinics in EnglandAda R Miltz, Alison J Rodger, Janey Sewell, et al.
Antiviral Therapy|May 29, 2008
Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trialAndrew N Phillips, Andrew Carr, Jacquie Neuhaus, et al.
The Lancet. Global Health|September 21, 2023
Potential cost-effectiveness of community availability of tenofovir, lamivudine, and dolutegravir for HIV prevention and treatment in east, central, southern, and west Africa: a modelling analysisAndrew N Phillips, Loveleen Bansi-Matharu, Maryam Shahmanesh, et al.
Bjpsych Open|May 17, 2017
Clinically significant depressive symptoms and sexual behaviour among men who have sex with menAda R Miltz, Alison J Rodger, Janey Sewell, et al.
Sexually Transmitted Infections|June 15, 2023
Predictors of starting and stopping chemsex in men who have sex with men in England: findings from the AURAH2 prospective studyRobbie Hammond, Valentina Cambiano, Fiona C Lampe, et al.
Pageof 29

Showing results (171-180 of 287) with videos related to

Sort By:
Pageof 29
BMC Medicine|April 3, 2016
Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaborationCaroline A Sabin, Peter Reiss, Lene Ryom, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 29, 2013
Association between ALT level and the rate of cardio/cerebrovascular events in HIV-positive individuals: the D: A: D studyCaroline A Sabin, Lene Ryom, Helen Kovari, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2010
Changes in lipids and lipoprotein particle concentrations after interruption of antiretroviral therapyFiona C Lampe, Daniel A Duprez, Lewis H Kuller, et al.
Journal of the International AIDS Society|July 23, 2019
Strengthening the scale-up and uptake of effective interventions for sex workers for population impact in ZimbabweFrances M Cowan, Sungai T Chabata, Sithembile Musemburi, et al.
Journal of the International AIDS Society|June 29, 2019
Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START studyJose R Castillo-Mancilla, Andrew N Phillips, James D Neaton, et al.
The International Journal on Drug Policy|January 25, 2021
Recreational drug use and use of drugs associated with chemsex among HIV-negative and HIV-positive heterosexual men and women attending sexual health and HIV clinics in EnglandAda R Miltz, Alison J Rodger, Janey Sewell, et al.
Antiviral Therapy|May 29, 2008
Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trialAndrew N Phillips, Andrew Carr, Jacquie Neuhaus, et al.
The Lancet. Global Health|September 21, 2023
Potential cost-effectiveness of community availability of tenofovir, lamivudine, and dolutegravir for HIV prevention and treatment in east, central, southern, and west Africa: a modelling analysisAndrew N Phillips, Loveleen Bansi-Matharu, Maryam Shahmanesh, et al.
Bjpsych Open|May 17, 2017
Clinically significant depressive symptoms and sexual behaviour among men who have sex with menAda R Miltz, Alison J Rodger, Janey Sewell, et al.
Sexually Transmitted Infections|June 15, 2023
Predictors of starting and stopping chemsex in men who have sex with men in England: findings from the AURAH2 prospective studyRobbie Hammond, Valentina Cambiano, Fiona C Lampe, et al.
Pageof 29